Stocks · Korea
204840
KOSDAQ
GL Pharm Tech
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-2.13%
1M-21.59%
3M+0.49%
6M-20.15%
1Y-22.83%
YTD-24.25%
52W high6,650원
52W low3,760원
From 52W high-37.74%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 167억 | -33억 | -8억 | -19.5% |
| 2023 | 260억 | -32억 | -37억 | -12.4% |
| 2024 | 260억 | -18억 | -23억 | -6.8% |
| 2025 | 353억 | 3억 | 12,489,192원 | 0.8% |
| Quarterly | ||||
| 2024 4Q | 86억 | 42,787,595원 | 93,427,879원 | 0.5% |
| 2025 1Q | 78억 | 1억 | 24,073,119원 | 1.6% |
| 2025 2Q | 84억 | 2억 | 57,055,750원 | 2.2% |
| 2025 3Q | 95억 | 3억 | 1억 | 2.6% |
| 2025 4Q | 95억 | -3억 | -2억 | -3.1% |
| 2026 1Q | 94억 | 34,628,475원 | -1억 | 0.4% |
Company
Address: 경기도 성남시 수정구 달래내로 46 성남글로벌융합센터 210호
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-06-01[첨부정정]주요사항보고서(회사합병결정) Major
- 2026-05-28주요사항보고서(회사합병결정) Major
- 2026-05-28[첨부정정]주요사항보고서(회사합병결정) Major
- 2026-05-13분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.